MyAverix Finance
HK · Healthcare
Essex Bio-Technology Ltd (1061)
Drug Manufacturers - Specialty & Generic
Essex Bio-Technology Ltd (1061) is listed on HK in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-21, reported market cap is $1.70B, P/E ratio is 5.36, net margin is 17.5%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 1061
Essex Bio-Technology Ltd (1061) — FAQ
What is Essex Bio-Technology Ltd's market cap?
Essex Bio-Technology Ltd (1061) has a reported market cap of $1.70B (data as of 2026-05-21).
What is 1061's P/E ratio?
The price-to-earnings (P/E) ratio for Essex Bio-Technology Ltd (1061) is 5.36 (data as of 2026-05-21).
Does Essex Bio-Technology Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Essex Bio-Technology Ltd (1061). Check the MyAverix Finance app for the latest dividend data.
What sector is Essex Bio-Technology Ltd in?
Essex Bio-Technology Ltd (1061) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 1061 listed on?
1061 is listed on HK.
What is Essex Bio-Technology Ltd's net margin?
Essex Bio-Technology Ltd (1061) reports a net margin of 17.5% (data as of 2026-05-21).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.